Literature DB >> 6526018

The penetration of antibiotics into the prostate in chronic bacterial prostatitis.

M Barza, G Cuchural.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6526018     DOI： 10.1007/bf02013607

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  13 in total

1.  The response of prostatic fluid pH in inflammation.

Authors:  N J Blacklock; J P Beavis
Journal:  Br J Urol       Date:  1974-10

2.  An appraisal of cephalexin monohydrate levels in semen and prostatic tissue.

Authors:  J M Symes; J D Jarvis; G C Tresidder
Journal:  Chemotherapy       Date:  1974       Impact factor: 2.544

3.  Diffusion of antibiotics from plasma into prostatic fluid.

Authors:  D G Winningham; N J Nemoy; T A Stamey
Journal:  Nature       Date:  1968-07-13       Impact factor: 49.962

4.  Diffusion of minocycline into prostatic secretion in dogs.

Authors:  W R Fair
Journal:  Urology       Date:  1974-03       Impact factor: 2.649

5.  Secretion of the antibacterial substance trimethoprim in the prostatic fluid of dogs.

Authors:  D S Reeves; M Ghilchik
Journal:  Br J Urol       Date:  1970-02

6.  The concentration of doxycycline in human prostate gland and its role in the treatment of prostatitis.

Authors:  W Oosterlinck; E Wallijn; J J Wijndaele
Journal:  Scand J Infect Dis Suppl       Date:  1976

7.  The pH of prostatic fluid: a reappraisal and therapeutic implications.

Authors:  W R Fair; J J Cordonnier
Journal:  J Urol       Date:  1978-12       Impact factor: 7.450

8.  A re-appraisal of treatment in chronic bacterial prostatitis.

Authors:  W R Fair; D B Crane; N Schiller; W D Heston
Journal:  J Urol       Date:  1979-04       Impact factor: 7.450

9.  Prostatic fluid and tissue concentrations of ampicillin after administration of hetacillin ester (BL-P1761).

Authors:  T B Kjaer; P O Madsen
Journal:  Invest Urol       Date:  1976-07

10.  Concentrations of doxycycline in human seminal plasma.

Authors:  R Eliasson; A S Malmborg
Journal:  Scand J Infect Dis Suppl       Date:  1976
View more
  6 in total

1.  Cefminox sodium penetration into prostatic tissue with and without inflammation.

Authors:  I Sasagawa; O Yamaguchi; Y Shiraiwa
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

Review 2.  Reducing infection rates after prostate biopsy.

Authors:  Florian M E Wagenlehner; Adrian Pilatz; Przemyslaw Waliszewski; Wolfgang Weidner; Truls E Bjerklund Johansen
Journal:  Nat Rev Urol       Date:  2014-01-14       Impact factor: 14.432

Review 3.  Anatomical barriers for antimicrobial agents.

Authors:  M Barza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993       Impact factor: 3.267

4.  Intraprostatic distribution of lomefloxacin following multiple-dose administration.

Authors:  J M Kovarik; J A de Hond; I M Hoepelman; T Boon; J Verhoef
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

Review 5.  Cefpirome clinical pharmacokinetics.

Authors:  L C Strenkoski; D E Nix
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

Review 6.  Treatment response to conventional and novel therapies in chronic prostatitis.

Authors:  Daniel A Shoskes
Journal:  Curr Urol Rep       Date:  2003-08       Impact factor: 2.862
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.